NASDAQ:DALS DA32 Life Science Tech Acquisition (DALS) Stock Price, News & Analysis Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$10.30▼$10.3250-Day Range$10.25▼$10.3252-Week Range$9.68▼$11.22Volume2,200 shsAverage Volume88,802 shsMarket Capitalization$264.71 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get DA32 Life Science Tech Acquisition alerts: Email Address Ad Paradigm PressEx-CIA Advisor: “This is How Kamala will Rig the Election”A former CIA advisor with close ties to the White House… Has just released this shocking expose on Kamala’s plan to stop Trump. Every American needs to prepare now…Click here now and learn how to prepare. About DA32 Life Science Tech Acquisition Stock (NASDAQ:DALS)DA32 Life Science Tech Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses in the biotechnology and life science infrastructure sectors. DA32 Life Science Tech Acquisition Corp. was incorporated in 2021 and is based in New York, New York.Read More Ad Paradigm PressEx-CIA Advisor: “This is How Kamala will Rig the Election”A former CIA advisor with close ties to the White House… Has just released this shocking expose on Kamala’s plan to stop Trump. Every American needs to prepare now…Click here now and learn how to prepare. DALS Stock News HeadlinesAugust 2, 2024 | investing.comGlobal Technology Acquisition Corp I (GTAC)July 19, 2024 | thestreet.comDA32 Life Science Tech Acquisition Corp.September 7, 2024 | Behind the Markets (Ad)NASDAQ to crash 50%?During the 2020 Covid Crash he called a market reversal - eleven days before the S&P bottomed out... Now, he's saying there are four major cracks forming in the US economy...May 29, 2024 | bizjournals.com5 lab trends driving opportunity in Boston's life sciences marketMay 27, 2024 | msn.comDefense tech startup BlueHalo makes lasers that shoot drones out of the sky. This is how it got the Army to buy them.May 21, 2024 | bizjournals.comLife sciences product launch, investment, and talent ecosystem key in Greater PhiladelphiaApril 26, 2024 | msn.comLife science SMEs “heading out of the funding winter”April 23, 2024 | finance.yahoo.comBellevue Life Sciences Acquisition Corp. (BLACU)September 7, 2024 | Behind the Markets (Ad)NASDAQ to crash 50%?During the 2020 Covid Crash he called a market reversal - eleven days before the S&P bottomed out... Now, he's saying there are four major cracks forming in the US economy...February 7, 2024 | news.yahoo.comDefense Innovation Unit’s tech-scaling strategy focuses on partnershipsDecember 29, 2023 | seekingalpha.comBLACR Bellevue Life Sciences Acquisition Corp.August 2, 2023 | finance.yahoo.comDeerfield Management Company, L.P. (Series C) Boosts Holding in DA32 Life Science Tech ...July 26, 2023 | usnews.comMissouri University of Science and TechnologyJuly 21, 2023 | finance.yahoo.comDA32 Life Science Tech Acquisition Corp. Announces Redemption of SharesJune 24, 2023 | uk.news.yahoo.comScore a gorgeous TV for a just $80 (that's 50% off) — plus 4 more epic tech deals todayJune 21, 2023 | investing.comLife Science Technology Inc (285770)May 2, 2023 | bizjournals.comDanaher completes merger of Cytiva and Pall Corp.'s life sciences businessApril 1, 2023 | cbsnews.comBest spring deals at Walmart this week: Save on home, tech, Easter and moreSee More Headlines Receive DALS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for DA32 Life Science Tech Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today9/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorUnclassified Industry Holding & other investment offices Sub-IndustryN/A Current SymbolNASDAQ:DALS CUSIPN/A CIK1863294 Webda32lifescience.tech Phone212551600FaxN/AEmployees2,021Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$600,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-37.55% Return on Assets0.85% Debt Debt-to-Equity RatioN/A Current Ratio0.36 Quick Ratio0.36 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash Flow$0.02 per share Price / Cash Flow441.92 Book Value($0.18) per share Price / Book-57.33Miscellaneous Outstanding SharesN/AFree FloatN/AMarket Cap$264.71 million OptionableNot Optionable BetaN/A (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesDr. Steven Kafka Ph.D. (Age 54)CEO & Director Mr. Christopher E. Wolfe (Age 43)CFO & Sec. Comp: $90kKey CompetitorsWorld Quantum Growth AcquisitionNYSE:WQGAArtemis Strategic InvestmentNASDAQ:ARTEEmerging Markets HorizonNASDAQ:HORIStoneBridge AcquisitionNASDAQ:APACHome Plate AcquisitionNASDAQ:HPLTView All Competitors DALS Stock Analysis - Frequently Asked Questions When did DA32 Life Science Tech Acquisition IPO? DA32 Life Science Tech Acquisition (DALS) raised $200 million in an IPO on Wednesday, July 28th 2021. The company issued 20,000,000 shares at a price of $10.00 per share. This page (NASDAQ:DALS) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DA32 Life Science Tech Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share DA32 Life Science Tech Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.